Lyell Immunopharma SG&A Expense (Quarterly) Trends

Lyell Immunopharma Inc (LYEL)

2.77 +0.11 (+4.14%) USD | NASDAQ | May 31, 16:00

2.74 -0.03 (-1.08%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	13.49M
December 31, 2023	13.17M
September 30, 2023	15.51M
June 30, 2023	19.03M
March 31, 2023	19.28M
December 31, 2022	26.35M
September 30, 2022	26.08M
June 30, 2022	30.45M
March 31, 2022	34.42M

Date	Value
December 31, 2021	31.87M
September 30, 2021	21.24M
June 30, 2021	19.11M
March 31, 2021	16.83M
December 31, 2020	14.87M
September 30, 2020	13.57M
June 30, 2020	9.562M
March 31, 2020	8.88M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

8.88M

Minimum

Mar 2020

34.42M

Maximum

Mar 2022

19.63M

Average

19.03M

Median

Jun 2023

SG&A Expense (Quarterly) Benchmarks